Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$2.66B |
| 2 |
Amazon
AMZN
|
+$421M |
| 3 |
Citigroup
C
|
+$386M |
| 4 |
Wells Fargo
WFC
|
+$288M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$287M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$3.18B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.45B |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$1.45B |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$533M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$503M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 92.99% |
| 2 | Technology | 1.99% |
| 3 | Consumer Discretionary | 1.08% |
| 4 | Financials | 1% |
| 5 | Communication Services | 0.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
Rithm Capital
RITM
$5.63B
| $10.4M | ﹤0.01% |
1,309,978
+47,901
| +4% | +$369K |
|
2102
CALL
ResMed
RMD
$34.5B
| $10.4M | ﹤0.01% |
60,700
+16,700
| +38% | +$3.08M |
|
2103
PUT
Incyte
INCY
$25.5B
| $10.4M | ﹤0.01% |
115,800
+28,700
| +33% | +$2.77M |
|
2104
Invesco China Technology ETF
CQQQ
$3.08B
| $10.4M | ﹤0.01% |
149,977
+143,120
| +2,087% | +$9.96M |
|
2105
PUT
IPG Photonics
IPGP
$3.28B
| $10.4M | ﹤0.01% |
61,000
-6,400
| -9% | -$1.06M |
|
2106
CALL
Northern Trust
NTRS
$34.2B
| $10.4M | ﹤0.01% |
132,900
-61,200
| -32% | -$4.91M |
|
|
BZUN
2107
CALL
Baozun
BZUN
$188M
| $10.4M | ﹤0.01% |
318,700
-153,100
| -32% | -$6.09M |
|
|
SINA
2108
CALL
DELISTED
Sina Corp
SINA
| $10.4M | ﹤0.01% |
243,000
+126,600
| +109% | +$5.09M |
|
2109
CALL
IQVIA
IQV
$43.1B
| $10.3M | ﹤0.01% |
65,500
-37,900
| -37% | -$5.94M |
|
|
GBT
2110
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $10.3M | ﹤0.01% |
187,100
+7,100
| +4% | +$451K |
|
2111
PUT
Sabre
SABR
$892M
| $10.3M | ﹤0.01% |
1,583,100
+921,600
| +139% | +$6.83M |
|
2112
CALL
Floor & Decor
FND
$5.67B
| $10.3M | ﹤0.01% |
137,400
-126,600
| -48% | -$8.7M |
|
2113
Gen Digital
GEN
$18.7B
| $10.3M | ﹤0.01% |
493,057
+109,497
| +29% | +$2.37M |
|
2114
Opko Health
OPK
$1.11B
| $10.3M | ﹤0.01% |
2,783,933
+1,074,620
| +63% | +$4.54M |
|
2115
CALL
Molina Healthcare
MOH
$10.4B
| $10.3M | ﹤0.01% |
56,100
+3,700
| +7% | +$673K |
|
2116
Sarepta Therapeutics
SRPT
$2.3B
| $10.3M | ﹤0.01% |
73,131
+44,255
| +153% | +$6.73M |
|
2117
CALL
Fluor
FLR
$7.16B
| $10.2M | ﹤0.01% |
1,161,700
-86,900
| -7% | -$914K |
|
2118
NetApp
NTAP
$37.5B
| $10.2M | ﹤0.01% |
233,408
+109,176
| +88% | +$4.76M |
|
|
ARR
2119
CALL
Armour Residential REIT
ARR
$2.33B
| $10.2M | ﹤0.01% |
215,080
+130,800
| +155% | +$6.24M |
|
|
NVRO
2120
CALL
DELISTED
NEVRO CORP.
NVRO
| $10.2M | ﹤0.01% |
73,300
-25,300
| -26% | -$3.38M |
|
2121
Realty Income
O
$58.7B
| $10.2M | ﹤0.01% |
173,277
+161,552
| +1,378% | +$9.55M |
|
2122
CALL
Neurocrine Biosciences
NBIX
$15.7B
| $10.2M | ﹤0.01% |
106,000
-40,400
| -28% | -$4.67M |
|
|
JNPR
2123
PUT
DELISTED
Juniper Networks
JNPR
| $10.2M | ﹤0.01% |
473,800
-145,200
| -23% | -$3.44M |
|
|
FITB
2124
PUT
Fifth Third Bancorp
FITB
$49.8B
| $10.2M | ﹤0.01% |
477,000
-332,400
| -41% | -$6.69M |
|
2125
O'Reilly Automotive
ORLY
$71.2B
| $10.2M | ﹤0.01% |
330,795
+94,215
| +40% | +$2.86M |
|
Similar funds
Jeff Yass's Q3 2020 Portfolio in Review
As of Q3 2020, Jeff Yass held 11,604 positions worth $522B, up 26% from $415B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Jeff Yass's Q3 2020 filing shows 1,567 new, 4,405 increased, 4,403 reduced and 1,138 closed positions. Its largest new stake was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M. The largest sale was Invesco QQQ Trust, an estimated $3.18B.
By sector, the portfolio is most concentrated in Miscellaneous at 93% of assets, up from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q3 2020 buy was iShares iBoxx $ Investment Grade Corporate Bond ETF: 2,104,687 shares worth $284M.
- Jeff Yass added most to Apple in Q3 2020, an estimated $2.66B increase.
- Jeff Yass's biggest Q3 2020 reduction was Invesco QQQ Trust, cutting an estimated $3.18B.
- Jeff Yass fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2020, selling an estimated $34.1M.
- Jeff Yass's ten largest holdings make up 34% of its $522B portfolio in Q3 2020.
- Jeff Yass opened 1,567 new positions and closed 1,138 in Q3 2020.
- Jeff Yass's portfolio value rose 26% quarter-over-quarter to $522B.
Based on Susquehanna International Group's 13F filing for Q3 2020, filed 16 Nov 2020.